Charles Conroy is the founder of Nucleus RadioPharma. Nucleus RadioPharma has raised $62M in total funding. Latest round: Series A.
Charles Conroy is the Chief Executive Officer of Nucleus RadioPharma, a Contract Development and Manufacturing Organization (CDMO) focused on radiopharmaceuticals for cancer treatments. He leads the company co-founded by Mayo Clinic and Eclipse Ventures, which raised $6 million in seed funding in 2022 and $56 million in Series A funding in 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library